|
US3734795A
(en)
|
1971-04-23 |
1973-05-22 |
Lindsay Wire Weaving Co |
Patch and seam for plastic belts
|
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
|
WO1998047343A2
(en)
|
1997-04-04 |
1998-10-29 |
Biosite Diagnostics, Inc. |
Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
|
|
US6140467A
(en)
|
1997-07-07 |
2000-10-31 |
La Jolla Institute For Allergy And Immunology |
Ligand for herpes simplex virus entry mediator and methods of use
|
|
US6998108B1
(en)
|
1997-07-07 |
2006-02-14 |
La Jolla Institute For Allergy And Immunology |
Antibodies to p30 polypeptides and methods making and using same
|
|
US7118742B2
(en)
|
1997-07-07 |
2006-10-10 |
La Jolla Institute For Allergy And Immunology |
Ligand for herpes simplex virus entry mediator and methods of use
|
|
DE60143231D1
(de)
|
2000-04-12 |
2010-11-18 |
Jolla Inst Allergy Immunolog |
Ligand des zelleintritt-vermittelnden Proteins von Herpes Simplex und Methoden zu dessen Verwendungen
|
|
EP1336619A3
(en)
|
2002-02-19 |
2003-12-10 |
Millenium Pharmaceuticals, Inc. |
Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
|
|
EP1499353A4
(en)
*
|
2002-04-15 |
2006-04-05 |
Human Genome Sciences Inc |
SPECIFIC TO TL5 BINDING ANTIBODIES
|
|
AU2007290570C1
(en)
|
2006-08-28 |
2013-08-15 |
Kyowa Kirin Co., Ltd. |
Antagonistic human LIGHT-specific human monoclonal antibodies
|
|
SI2292663T1
(sl)
*
|
2006-08-28 |
2014-02-28 |
Kyowa Hakko Kirin Co., Ltd |
Antagonistična humana monoklonska protitelesa, specifična za humani LIGHT
|
|
US8440185B2
(en)
|
2006-12-26 |
2013-05-14 |
The Johns Hopkins University |
Compositions and methods for the treatment of immunologic disorders
|
|
JP6071165B2
(ja)
|
2007-05-31 |
2017-02-01 |
ゲンマブ エー／エス |
安定なＩｇＧ４抗体
|
|
US20090136427A1
(en)
|
2007-09-18 |
2009-05-28 |
La Jolla Institute For Allergy And Immunology |
LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment
|
|
WO2010051502A2
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
WO2010111180A1
(en)
|
2009-03-24 |
2010-09-30 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against light and uses thereof
|
|
EP4527855A3
(en)
|
2012-03-26 |
2025-06-11 |
Sanofi |
Stable igg4 based binding agent formulations
|
|
WO2013148350A2
(en)
*
|
2012-03-26 |
2013-10-03 |
Sanofi |
Anti-light antibody therapy for inflammatory bowel disease
|
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
|
EP3041831B1
(en)
|
2013-09-06 |
2019-10-23 |
Research Development Foundation |
Alpha-tea salt forms: compositions and uses for treating disease
|
|
EA201690746A1
(ru)
|
2013-10-25 |
2016-12-30 |
Фармасайкликс Элэлси |
Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии
|
|
EP3094651B1
(en)
|
2014-01-14 |
2020-03-11 |
Kymab Limited |
Anti-light antibodies
|
|
CA2945263A1
(en)
|
2014-04-09 |
2015-10-15 |
Christopher Rudd |
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
|
|
WO2016127059A2
(en)
|
2015-02-05 |
2016-08-11 |
La Jolla Institute For Allergy And Immunology |
Light inhibitors for scleroderma and skin fibrotic disease treatment
|
|
EP3730188B1
(en)
|
2015-08-21 |
2024-07-31 |
The Children's Hospital of Philadelphia |
Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases
|
|
US11312781B2
(en)
*
|
2018-01-24 |
2022-04-26 |
Capella Bioscience Ltd. |
Antigen binding molecules that bind LIGHT
|